Skip Navigation

Cardiovascular Research 2001 52(2):217-225; doi:10.1016/S0008-6363(01)00377-7
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Shi, Y.
Right arrow Articles by Tardif, J.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shi, Y.
Right arrow Articles by Tardif, J.-C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2001, European Society of Cardiology

Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation

Yanfen Shia, Anique Ducharmea, Danshi Lia, Rania Gaspoa, Stanley Nattela,b,* and Jean-Claude Tardifa

aDepartment of Medicine, Montreal Heart Institute and University of Montreal, 5000 Belanger Street East, Montreal, Quebec, Canada H1T 1C8
bDepartment of Pharmacology and Therapeutics, McGill University, 3655 Promenade Sir William Osler, Montreal, Quebec, Canada H3G 1Y6

* Corresponding author. Tel.: +1-514-376-3330 ext. 3990; fax: +1-514-376-1355 nattel{at}icm.umontreal.ca

Objectives: Atrial tachycardia-induced remodeling (ATR) and ventricular tachypacing-induced heart failure (HF) create experimental substrates for atrial fibrillation (AF), and both have been reported to produce atrial dilation and hypocontractility. The relative importance of changes in atrial size and contractility in the two models is unknown. This study compared changes in atrial dimensions and emptying in ATR versus HF dog models and related them to AF promotion. Methods: In ATR dogs (n=11), the right atrium (RA) was paced at 400/min for 42 days. In HF dogs (n=10), the right ventricle was paced at 240 bpm for 2 weeks, followed by 3 weeks at 220 bpm. Transthoracic echocardiography was performed at baseline and weekly thereafter. At a terminal electrophysiological study, RA effective refractory period (ERP) was recorded and AF induced repeatedly by atrial burst pacing to measure mean AF duration (DAF). Results: Left atrial (LA) systolic area increased by 10.0% in ATR versus 48.2% in HF dogs (P=0.008), with significant time-dependent changes in HF (P=0.0001), but not ATR (P=0.16). LA diastolic area increased over time in both groups (P=0.004, 0.0001 for ATR and HF respectively), but increases were much larger in CHF (80.2%) compared to ATR (24.2%, P=0.0002). Similar findings were obtained for RA. Fractional area shortening (FAS) decreased by 19.4% (ATR) versus 41.8% (HF, P=0.007) in LA and 13.7% (ATR) versus 33.7% (HF, P=0.03) in RA. RA ERP correlated with DAF in ATR dogs (r=–0.79, P<0.001), but not in HF dogs (r=0.20, P=NS). DAF and diastolic areas of RA and LA were highly correlated (r=0.71, 0.77; P<0.01 for each) in HF dogs, but not in ATR dogs (r=–0.18, 0.29; P=NS). Conclusions: Remodeling of atrial size and emptying function is much greater in HF than in ATR. Whereas in ATR, electrophysiological remodeling is of prime importance in AF promotion, structural remodeling (as reflected in changes in atrial size and contraction) appears much more important in HF-induced AF.

KEYWORDS Arrhythmia (mechanisms); Atrial function; Heart failure; Remodeling; Supraventr. arrhythmia


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ Heart FailHome page
K. M. Dibb, J. D. Clarke, M. A. Horn, M. A. Richards, H. K. Graham, D. A. Eisner, and A. W. Trafford
Characterization of an Extensive Transverse Tubular Network in Sheep Atrial Myocytes and its Depletion in Heart Failure
Circ Heart Fail, September 1, 2009; 2(5): 482 - 489.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
J. L. Serra and M. Bendersky
Review: Atrial fibrillation and renin-angiotensin system
Therapeutic Advances in Cardiovascular Disease, June 1, 2008; 2(3): 215 - 223.
[Abstract] [PDF]


Home page
Circ Arrhythm ElectrophysiolHome page
S. Nattel, B. Burstein, and D. Dobrev
Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications
Circ Arrhythm Electrophysiol, April 1, 2008; 1(1): 62 - 73.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Laurent, G. Moe, X. Hu, H. Leong-Poi, K. A. Connelly, P. P.-S. So, A. Ramadeen, L. Doumanovskaia, A. Konig, J. Trogadis, et al.
Experimental studies of atrial fibrillation: a comparison of two pacing models
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1206 - H1215.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Casaclang-Verzosa, B. J. Gersh, and T. S.M. Tsang
Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation.
J. Am. Coll. Cardiol., January 1, 2008; 51(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. P. Regan, L. Kiss, G. L. Stump, C. J. McIntyre, D. C. Beshore, N. J. Liverton, C. J. Dinsmore, and J. J. Lynch Jr.
Atrial Antifibrillatory Effects of Structurally Distinct IKur Blockers 3-[(Dimethylamino)methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2H)-one and 2-Phenyl-1,1-dipyridin-3-yl-2-pyrrolidin-1-yl-ethanol in Dogs with Underlying Heart Failure
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 322 - 330.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. S. Healey, A. Baranchuk, E. Crystal, C. A. Morillo, M. Garfinkle, S. Yusuf, and S. J. Connolly
Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis
J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1832 - 1839.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Monnet and J. C. Chachques
Animal Models of Heart Failure: What Is New?
Ann. Thorac. Surg., April 1, 2005; 79(4): 1445 - 1453.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. G. Bourassa
Angiotensin II inhibition and prevention of atrial fibrillation and stroke
J. Am. Coll. Cardiol., March 1, 2005; 45(5): 720 - 721.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Verheule, E. Wilson, S. Banthia, T. H. Everett IV, S. Shanbhag, H. J. Sih, and J. Olgin
Direction-dependent conduction abnormalities in a canine model of atrial fibrillation due to chronic atrial dilatation
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H634 - H644.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Hanna, S. Cardin, T.-K. Leung, and S. Nattel
Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure
Cardiovasc Res, August 1, 2004; 63(2): 236 - 244.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Cardin, D. Li, N. Thorin-Trescases, T.-K. Leung, E. Thorin, and S. Nattel
Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways
Cardiovasc Res, November 1, 2003; 60(2): 315 - 325.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Vermes, J.-C. Tardif, M. G. Bourassa, N. Racine, S. Levesque, M. White, P. G. Guerra, and A. Ducharme
Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular Dysfunction: Insight From the Studies Of Left Ventricular Dysfunction (SOLVD) Trials
Circulation, June 17, 2003; 107(23): 2926 - 2931.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Verheule, E. Wilson, T. Everett IV, S. Shanbhag, C. Golden, and J. Olgin
Alterations in Atrial Electrophysiology and Tissue Structure in a Canine Model of Chronic Atrial Dilatation Due to Mitral Regurgitation
Circulation, May 27, 2003; 107(20): 2615 - 2622.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
U. Schotten, M. Duytschaever, J. Ausma, S. Eijsbouts, H.-R. Neuberger, and M. Allessie
Electrical and Contractile Remodeling During the First Days of Atrial Fibrillation Go Hand in Hand
Circulation, March 18, 2003; 107(10): 1433 - 1439.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Shinagawa, Y.-F. Shi, J.-C. Tardif, T.-K. Leung, and S. Nattel
Dynamic Nature of Atrial Fibrillation Substrate During Development and Reversal of Heart Failure in Dogs
Circulation, June 4, 2002; 105(22): 2672 - 2678.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. L. Mehta and D. Li
Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor
J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1429 - 1435.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Allessie, J. Ausma, and U. Schotten
Electrical, contractile and structural remodeling during atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 230 - 246.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Nattel
Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management?
Cardiovasc Res, May 1, 2002; 54(2): 347 - 360.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. B Schuessler
Establishing the link between a specific pathology and atrial fibrillation
Cardiovasc Res, November 1, 2001; 52(2): 169 - 170.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.